I dumped PLTK for a 4% loss after they eliminated their dividend for nebulous reasons.

I sold another 25% of VNDA for a 94% gain.

I bought more PERI at $8.18. It was trading at $.53 over its cash value and at about .5X earnings net of their cash.

ACH just can’t get going. Trading at about 3X earnings. Thinking about buying more if the weakness continues.

They got another FDA approval on Friday. Up 40% today in a bad market. #2 gainer on NASDAQ. Still holding 75%.

I got whacked a bit by the market since my last update, but still decently in the black for the year.

PERI announced earnings. Let’s see….. Non-GAAP income was $.49 up from $.33 last year. Made $1.13 for the year, and have $7.65 a share in net cash–after they bought back $71 million of their own stock in 2025. They expect at least a 10% increase in EBITDA for 2026 which should translate to the same type of EPS increase. Trading at $1.35 above net cash value. Just insane.

VNDA got their second FDA approval on Friday. The stock was up 44% after hours.

ACH reported earnings. EPS was $.21 for the quarter (from continuing operations) and $1.01 for the year. They lost a low margin contract, so revenues will drop about 7% in 2026 and EBITDA will drop 5-10%. So EPS may “only” be about $.90. Trading at $2.60, 2.9X forward EPS. Yes, they have a pile of debt, but this is way CHEAP, IMO.

I managed to avoid the plunge in NASDAQ over the last few weeks.

I did a trade on DHX and booked a 50% profit in a month. This must be at least the 5th time I have traded this stock over the years. Buy at $1.50 ish and sell at $2.50-$3.00.

I bought some more NEXN today. An X report came out that someone is thinking of buying them for at least $10 a share. Last I looked they had about $2 a share in cash and will make about $.90 a share for 2025. I think it is worth $11-$14 a share and is way cheap at $6.